Md Lutful Amin

Dr. Md Lutful Amin


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Drug Target Insights
Verified
Journal Article
Open access
MAMd Lutful Amin
Md Lutful Amin
P-glycoprotein (P-gp), an efflux membrane transporter, is widely distributed throughout the body and is responsible for limiting cellular uptake and the distrib...

29 June 2016 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
MAMd Lutful Amin
Md Lutful Amin
TATajnin Ahmed
Tajnin Ahmed
AMAbdul Mannan
Abdul Mannan
Development of Floating-Mucoadhesive Microsphere for Site Specific Release of Metronidazole

1 February 2021 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
MAMd Lutful Amin
Md Lutful Amin
DMDamia Mawad
Damia Mawad
SDSocrates Dokos
Socrates Dokos
PKPramod Koshy
Pramod Koshy
PMPenny Jo Martens
Penny Jo Martens
Charles C. SorrellCharles C. Sorrell
Charles C. Sorrell

1 November 2013 in Current Drug Delivery
Verified
Journal Article
Closed access
PDF file
MAMd Lutful Amin
Md Lutful Amin
TJTasbira Jesmeen
Tasbira Jesmeen
Kumar Bishwajit SutradharKumar Bishwajit Sutradhar
Kumar Bishwajit Sutradhar
AMAbdul Mannan
Abdul Mannan
The objective of this study was to develop and evaluate mucoadhesive microsphere of diclofenac sodium with natural gums for sustained delivery. Guar gum and tragacanth were used along with sodium alginate as mucoadhesive polymers. Microspheres were formulated using orifice-ionic gelation method. Particle size, surface morphology, swelling study and drug entrapment efficiency of the prepared microspheres were determined. In vitro evaluation was carried out comprising of mucoadhesion and drug release study. The prepared microspheres were discrete and free flowing. Sodium alginate and natural gum, at a ratio of 1:0.25, showed good mucoadhesive property and they had high drug entrapment efficiencies. They also exhibited the best rate retarding effect among all the formulations. Drug entrapment efficiency of all the microspheres ranged from 80.42% to 91.67%. An inverse relationship was found between extent of crosslinking and drug release rate. Release rate was slow and extended in case of the formulations of 1:0.25 ratio (F1 and F3), releasing 68.36% and 70.56% drug respectively after 8 hours. Tragacanth-containing microspheres of F1 showed superiority over other formulations, with best mucoadhesive and rate retarding profile. The correlation value (r2) indicated that the drug release of all the formulations followed Higuchi’s model. Overall, the results indicated that mucoadhesive microspheres containing natural gum can be promising in terms of prolonged delivery with good mucoadhesive action, targeting the absorption site to thrive oral drug delivery.

30 March 2024 in Biomacromolecules
Verified
Journal Article
Closed access
MAMd Lutful Amin
Md Lutful Amin
DMDamia Mawad
Damia Mawad
SDSocrates Dokos
Socrates Dokos
CSCharles C. Sorrell
Charles C. Sorrell

23 November 2022 in Bioengineering
Verified
Journal Article
Open access
PDF file
MAMd Lutful Amin
Md Lutful Amin
KDKylie Deng
Kylie Deng
HTHien A. Tran
Hien A. Tran
RSReena Singh
Reena Singh
JRJelena Rnjak-Kovacina
Jelena Rnjak-Kovacina
PTPeter Thorn
Peter Thorn
Type 1 diabetes results from the loss of pancreatic β cells, reduced insulin secretion and dysregulated blood glucose levels. Replacement of these lost β cells with stem cell-derived β cells, and protecting these cells within macro-device implants is a promising approach to restore glucose homeostasis. However, to achieve this goal of restoration of glucose balance requires work to optimise β cell function within implants. We know that native β cell function is enhanced by cell–cell and cell–extracellular matrix interactions within the islets of Langerhans. Reproducing these interactions in 2D, such as culture on matrix proteins, does enhance insulin secretion. However, the impact of matrix proteins on the 3D organoids that would be in implants has not been widely studied. Here, we use native β cells that are dispersed from islets and reaggregated into small spheroids. We show these β cell spheroids have enhanced glucose-dependent insulin secretion when embedded into softer alginate hydrogels conjugated with RGD peptide (a common motif in extracellular matrix proteins). Embedding into alginate–RGD causes activation of integrin responses and repositioning of liprin, a protein that controls insulin secretion. We conclude that insulin secretion from β cell spheroids can be enhanced through manipulation of the surrounding environment.